[
    [
        {
            "time": "2019-05-03",
            "original_text": "Pre-Market Earnings Report for May 3, 2019: AMT, D, TRP, FCAU, WPC, VST, NBL, BIP, CBOE, XRAY, NVO, DISH",
            "features": {
                "keywords": [
                    "Earnings",
                    "Pre-Market",
                    "AMT",
                    "D",
                    "TRP",
                    "FCAU",
                    "WPC",
                    "VST",
                    "NBL",
                    "BIP",
                    "CBOE",
                    "XRAY",
                    "NVO",
                    "DISH"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "finance",
                    "healthcare",
                    "technology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Pre-Market Earnings Report for May 3, 2019: AMT, D, TRP, FCAU, WPC, VST, NBL, BIP, CBOE, XRAY, NVO, DISH",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "2019-05-03",
            "original_text": "What's in the Cards for AEterna (AEZS) This Earnings Season?",
            "features": {
                "keywords": [
                    "Earnings",
                    "AEterna",
                    "AEZS"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "What's in the Cards for AEterna (AEZS) This Earnings Season?",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 4
            }
        },
        {
            "time": "2019-05-03",
            "original_text": "Why Earnings Season Could Be Great for Novo Nordisk (NVO)",
            "features": {
                "keywords": [
                    "Earnings",
                    "Season",
                    "Novo",
                    "Nordisk",
                    "NVO"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Why Earnings Season Could Be Great for Novo Nordisk (NVO)",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2019-05-03",
            "original_text": "Strongbridge Biopharma (SBBP) Q1 2019 Earnings Call Transcript",
            "features": {
                "keywords": [
                    "Strongbridge",
                    "Biopharma",
                    "SBBP",
                    "Q1",
                    "2019",
                    "Earnings",
                    "Call",
                    "Transcript"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Strongbridge Biopharma (SBBP) Q1 2019 Earnings Call Transcript",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        }
    ]
]